Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
A011401 permanently closed to patient randomization (Step 2), effective March 25, 2021.
A011401 is permanently closed to new patient accrual (Step 1), effective February 15, 2021.
